 | • レポートコード：MRC2210A0096 • 出版社/出版日：Transparency Market Research / 2022年7月 • レポート形態：英文、PDF、180ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートでは、世界のあざ治療市場規模について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、疾患種類別（血腫、紫斑病、点状出血、その他）分析、適応症別（出血性疾患、ビタミン欠乏症、皮膚障害、その他）分析、治療種類別（抗凝固剤、抗炎症剤）分析、エンドユーザー別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況など、以下の項目を掲載しております。本書では、Arnicare Boiron、STADA、Bioderma、Zealous Health Private Limited、Pharmavite,LLC、Topix Pharmaceuticals,Inc.、TriDerma、Other prominent playersなどの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界のあざ治療市場規模：疾患種類別 - 血腫治療の市場規模 - 紫斑病治療の市場規模 - 点状出血治療の市場規模 - その他疾患種類の市場規模 ・世界のあざ治療市場規模：適応症別 - 出血性疾患治療の市場規模 - ビタミン欠乏症治療の市場規模 - 皮膚障害治療の市場規模 - その他適応症の市場規模 ・世界のあざ治療市場規模：治療種類別 - あざ治療用抗凝固剤の市場規模 - あざ治療用抗炎症剤の市場規模 ・世界のあざ治療市場規模：エンドユーザー別 - 病院薬局における市場規模 - 小売薬局における市場規模 - オンライン薬局における市場規模 ・世界のあざ治療市場規模：地域別 - 北米のあざ治療市場規模 - ヨーロッパのあざ治療市場規模 - アジア太平洋のあざ治療市場規模 - 中南米のあざ治療市場規模 - 中東/アフリカのあざ治療市場規模 ・競争状況 |
Bruise Treatment Market – Scope of Report
TMR’s report on the global bruise treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global bruise treatment market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bruise treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the bruise treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bruise treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global bruise treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bruise treatment market.
The report delves into the competitive landscape of the global bruise treatment market. Key players operating in the global bruise treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global bruise treatment market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market bruise treatment.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bruise Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Disease Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bruise Treatment Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Regulatory Scenario by Region/globally
5.3. Major Research Institutes Involved
6. Global Bruise Treatment Market Analysis and Forecast, by Disease Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Disease Type, 2017–2031
6.3.1. Hematoma
6.3.2. Purpura
6.3.3. Petechiae
6.3.4. Others
6.4. Market Attractiveness Analysis, by Disease Type
7. Global Bruise Treatment Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Bleeding Disorder
7.3.2. Vitamin Deficiencies
7.3.3. Skin Injury
7.3.4. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Bruise Treatment Market Analysis and Forecast, by Treatment Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Treatment Type, 2017–2031
8.3.1. Anti-coagulant Drugs
8.3.2. Anti-inflammatory Drugs
8.4. Market Attractiveness Analysis, by Treatment Type
9. Global Bruise Treatment Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Sales
9.4. Market Attractiveness Analysis, by End-user
10. Global Bruise Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Bruise Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Disease Type, 2017–2031
11.2.1. Hematoma
11.2.2. Purpura
11.2.3. Petechiae
11.2.4. Others
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Bleeding Disorder
11.3.2. Vitamin Deficiencies
11.3.3. Skin Injury
11.3.4. Others
11.4. Market Value Forecast, by Treatment Type, 2017–2031
11.4.1. Anti-coagulant Drugs
11.4.2. Anti-inflammatory Drugs
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Sales
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Disease Type
11.7.2. By Indication
11.7.3. By Treatment Type
11.7.4. By End-user
11.7.5. By Country
12. Europe Bruise Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Disease Type, 2017–2031
12.2.1. Hematoma
12.2.2. Purpura
12.2.3. Petechiae
12.2.4. Others
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Bleeding Disorder
12.3.2. Vitamin Deficiencies
12.3.3. Skin Injury
12.3.4. Others
12.4. Market Value Forecast, by Treatment Type, 2017–2031
12.4.1. Anti-coagulant Drugs
12.4.2. Anti-inflammatory Drugs
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Sales
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Disease Type
12.7.2. By Indication
12.7.3. By Treatment Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Bruise Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Disease Type, 2017–2031
13.2.1. Hematoma
13.2.2. Purpura
13.2.3. Petechiae
13.2.4. Others
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Bleeding Disorder
13.3.2. Vitamin Deficiencies
13.3.3. Skin Injury
13.3.4. Others
13.4. Market Value Forecast, by Treatment Type, 2017–2031
13.4.1. Anti-coagulant Drugs
13.4.2. Anti-inflammatory Drugs
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Sales
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Disease Type
13.7.2. By Indication
13.7.3. By Treatment Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Bruise Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Disease Type, 2017–2031
14.2.1. Hematoma
14.2.2. Purpura
14.2.3. Petechiae
14.2.4. Others
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Bleeding Disorder
14.3.2. Vitamin Deficiencies
14.3.3. Skin Injury
14.3.4. Others
14.4. Market Value Forecast, by Treatment Type, 2017–2031
14.4.1. Anti-coagulant Drugs
14.4.2. Anti-inflammatory Drugs
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Sales
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Disease Type
14.7.2. By Indication
14.7.3. By Treatment Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Bruise Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Disease Type, 2017–2031
15.2.1. Hematoma
15.2.2. Purpura
15.2.3. Petechiae
15.2.4. Others
15.3. Market Value Forecast, by Indication, 2017–2031
15.3.1. Bleeding Disorder
15.3.2. Vitamin Deficiencies
15.3.3. Skin Injury
15.3.4. Others
15.4. Market Value Forecast, by Treatment Type, 2017–2031
15.4.1. Anti-coagulant Drugs
15.4.2. Anti-inflammatory Drugs
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Sales
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Disease Type
15.7.2. By Indication
15.7.3. By Treatment Type
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2021
16.3. Company Profiles
16.3.1. Arnicare Boiron
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. STADA
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. Bioderma
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. Zealous Health Private Limited.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Pharmavite, LLC.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Topix Pharmaceuticals, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. TriDerma
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
Table 01: Global Bruise Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2022 and 2031
Table 02: Global Bruise Treatment Market Value (US$ Mn) Forecast, by Indication, 2022 and 2031
Table 03: Global Bruise Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2022 and 2031
Table 04: Global Bruise Treatment Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 05: Global Bruise Treatment Market Value (US$ Mn) Forecast, by Region, 2022 and 2031
Table 06: North America Bruise Treatment Market Value (US$ Mn) Forecast, by Country, 2022 and 2031
Table 07: North America Bruise Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2022 and 2031
Table 08: North America Bruise Treatment Market Value (US$ Mn) Forecast, by Indication, 2022 and 2031
Table 09: North America Bruise Treatment Market Value (US$ Mn) Forecast, by Disease Type 2022 and 2031
Table 10: North America Bruise Treatment Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 11: Europe Bruise Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 and 2031
Table 12: Europe Bruise Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2022 and 2031
Table 13: Europe Bruise Treatment Market Value (US$ Mn) Forecast, by Indication, 2022 and 2031
Table 14: Europe Bruise Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2022 and 2031
Table 15: Europe Bruise Treatment Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 16: Asia Pacific Bruise Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 and 2031
Table 17: Asia Pacific Bruise Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2022 and 2031
Table 18: Asia Pacific Bruise Treatment Market Value (US$ Mn) Forecast, by Indication, 2022 and 2031
Table 19: Asia Pacific Bruise Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2022 and 2031
Table 20: Asia Pacific Bruise Treatment Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 21: Latin America Bruise Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 and 2031
Table 22: Latin America Bruise Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2022 and 2031
Table 23: Latin America Bruise Treatment Market Value (US$ Mn) Forecast, by Indication, 2022 and 2031
Table 24: Latin America Bruise Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2022 and 2031
Table 25: Latin America Bruise Treatment Market Value (US$ Mn) Forecast, by End-user, 2022 and 2031
Table 26: Middle East & Africa Bruise Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022 and 2031
Table 27: Middle East & Africa Bruise Treatment Market Value (US$ Mn) Forecast, by Disease Type, 2022 and 2031
Table 28: Middle East & Africa Bruise Treatment Market Value (US$ Mn) Forecast, by Indication 2022 and 2031
Table 29: Middle East & Africa Bruise Treatment Market Value (US$ Mn) Forecast, by Treatment Type 2022 and 2031
Table 30: Middle East & Africa Bruise Treatment Market Value (US$ Mn) Forecast, by End-user 2022 and 2031